SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:5bf4f0df-cfd2-4424-8867-0f8240b6c3fc"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:5bf4f0df-cfd2-4424-8867-0f8240b6c3fc" > Prospective evaluat...

Prospective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial : Cross-sectional evaluation of coronary flow reserve

Haraldsson, Inger (författare)
Sahlgrenska University Hospital,Sahlgrenska Academy
Gan, Li Ming (författare)
Sahlgrenska University Hospital,AstraZeneca, Sweden,Sahlgrenska Academy
Svedlund, Sara (författare)
Sahlgrenska University Hospital,Sahlgrenska Academy
visa fler...
Torngren, Kristina (författare)
Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups
Westergren, Helena U. (författare)
AstraZeneca, Sweden
Redfors, Björn (författare)
Sahlgrenska Academy,Sahlgrenska University Hospital
Lagerström-Fermér, Maria (författare)
AstraZeneca, Sweden
Angerås, Oskar (författare)
Sahlgrenska Academy,Sahlgrenska University Hospital
Råmunddal, Truls (författare)
Sahlgrenska Academy,Sahlgrenska University Hospital
Petursson, Petur (författare)
Sahlgrenska University Hospital,Sahlgrenska Academy
Odenstedt, Jacob (författare)
Sahlgrenska Academy,Sahlgrenska University Hospital
Albertsson, Per (författare)
Sahlgrenska University Hospital,Sahlgrenska Academy
Erlinge, David (författare)
Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups
Omerovic, Elmir (författare)
Sahlgrenska Academy,Sahlgrenska University Hospital
visa färre...
 (creator_code:org_t)
2019
2019
Engelska.
Ingår i: Vascular Health and Risk Management. - 1178-2048. ; 15, s. 375-384
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Survivors of myocardial infarction (MI) are at high risk of new major adverse cardiovascular events (MACE). Coronary flow reserve (CFR) is a strong and independent predictor of MACE. Understanding the prevalence of impaired CFR in this patient group and identifying risk markers for impaired CFR are important steps in the development of personalized and targeted treatment for high-risk individuals with prior MI. Methods: PROFLOW is a prospective, exploratory, cross-sectional open study. We used information from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) to identify high-risk patients with a history of type-1 MI. We measured CFR non-invasively in a left anterior descending artery (LAD) using transthoracic Doppler echocardiography. Coronary flow velocity was measured at rest and at maximal flow after induction of hyperemia by intravenous infusion of adenosine (140 μg/kg/min). Independent predictors of CFR were assessed with multiple linear regression. Results: We included 619 patients. The median age was 69 (IQR 65–73), and 114 (18.4%) were women. Almost one-half of the patients, 285 (46.0%) had the multi-vessel disease, and 147 (23.7%) were incompletely revascularized. The majority were on optimal standard treatment eg ASA (93.1%), statins (90.0%), ACEI/ARB (82.6%) and beta-blockers (80.8%). The majority, 547 (88.4%) had no angina pectoris, and 572 (92.2%) were in NYHA class I. Evaluation of CFR was possible in 611 (98.7%) patients. Mean CFR was 2.74 (±0.79 (mean ± SD)). A substantial number of patients (39.7%) had CFR ≤2.5. In a multiple linear regression model age, dyslipidemia, smoking, hypertension, body mass index, incomplete revascularization, and treatment with angio-tensin receptor blockers were independent predictors of CFR. Conclusion: In this high-risk group of patients with prior MI, the prevalence of impaired CFR was high. Further risk stratification with CFR in addition to traditional cardiovascular risk factors may improve predictive accuracy for future MACE in this patient population.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Coronary flow reserve
Doppler echocardiography
Myocardial infarction
Prognosis
Secondary prevention

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy